Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.
King J, Palmer DH, Johnson P, Ross P, Hubner RA, Sumpter K, Darby S, Braconi C, Iwuji C, Swinson D, Collins P, Patel K, Nobes J, Muazzam I, Blesing C, Kirkwood A, Nash S, Meyer T. King J, et al. Among authors: collins p. Clin Oncol (R Coll Radiol). 2017 Apr;29(4):256-262. doi: 10.1016/j.clon.2016.11.012. Epub 2016 Dec 10. Clin Oncol (R Coll Radiol). 2017. PMID: 27964898 Free article.
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
Edeline J, Blanc JF, Johnson P, Campillo-Gimenez B, Ross P, Ma YT, King J, Hubner RA, Sumpter K, Darby S, Evans J, Iwuji C, Swinson D, Collins P, Patel K, Muazzam I, Palmer DH, Meyer T. Edeline J, et al. Among authors: collins p. Liver Int. 2016 Dec;36(12):1821-1828. doi: 10.1111/liv.13170. Epub 2016 Jun 22. Liver Int. 2016. PMID: 27214151 Free article.
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
Meyer T, Fox R, Ma YT, Ross PJ, James MW, Sturgess R, Stubbs C, Stocken DD, Wall L, Watkinson A, Hacking N, Evans TRJ, Collins P, Hubner RA, Cunningham D, Primrose JN, Johnson PJ, Palmer DH. Meyer T, et al. Among authors: collins p. Lancet Gastroenterol Hepatol. 2017 Aug;2(8):565-575. doi: 10.1016/S2468-1253(17)30156-5. Epub 2017 Jun 23. Lancet Gastroenterol Hepatol. 2017. PMID: 28648803 Free article. Clinical Trial.
A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinoma.
Cross TJS, Villanueva A, Shetty S, Wilkes E, Collins P, Adair A, Jones RL, Foxton MR, Meyer T, Stern N, Warshow U, Khan N, Prince M, Khakoo S, Alexander GJ, Khan S, Reeves H, Marshall A, Williams R. Cross TJS, et al. Among authors: collins p. Frontline Gastroenterol. 2016 Apr;7(2):82-89. doi: 10.1136/flgastro-2015-100617. Epub 2015 Dec 7. Frontline Gastroenterol. 2016. PMID: 28840911 Free PMC article.
Quality of life changes in patients undergoing treatment for hepatocellular carcinoma.
Chie WC, Yu F, Li M, Baccaglini L, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, Al-Kadhimi G, Heaton N, Calara J, Collins P, Caddick K, Costantini A, Vilgrain V, Chiang C. Chie WC, et al. Among authors: collins p. Qual Life Res. 2015 Oct;24(10):2499-506. doi: 10.1007/s11136-015-0985-8. Epub 2015 May 6. Qual Life Res. 2015. PMID: 25943170
Drug therapies in liver disease.
Collins P, Ayres L, Valliani T. Collins P, et al. Clin Med (Lond). 2013 Dec;13(6):585-91. doi: 10.7861/clinmedicine.13-6-585. Clin Med (Lond). 2013. PMID: 24298107 Free PMC article. Review.
Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma.
Chie WC, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, Al-Kadhim G, Heaton N, Calara J, Collins P, Caddick K, Costantini A, Vilgrain V; Chieh Chiang, on behalf of the EORTC Quality of Life Group. Chie WC, et al. Among authors: collins p. Asia Pac J Clin Oncol. 2017 Oct;13(5):e304-e311. doi: 10.1111/ajco.12464. Epub 2016 Apr 1. Asia Pac J Clin Oncol. 2017. PMID: 27038366
Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention.
Hudson BE, Ameneshoa K, Gopfert A, Goddard R, Forbes K, Verne J, Collins P, Gordon F, Portal AJ, Reid C, McCune CA. Hudson BE, et al. Among authors: collins p. Frontline Gastroenterol. 2017 Jan;8(1):45-52. doi: 10.1136/flgastro-2016-100734. Epub 2016 Oct 5. Frontline Gastroenterol. 2017. PMID: 28839884 Free PMC article.
Molecular targets in the treatment of alcoholic hepatitis.
Dhanda AD, Lee RW, Collins PL, McCune CA. Dhanda AD, et al. World J Gastroenterol. 2012 Oct 21;18(39):5504-13. doi: 10.3748/wjg.v18.i39.5504. World J Gastroenterol. 2012. PMID: 23112542 Free PMC article. Review.
2,663 results